$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How to delay Selinisol (Silvio) resistance and prolong its efficacy
2026-02-01 22:25:32
Check Details
Onset time and efficacy evaluation of Vigabatrin (Okeda) in the treatment of epilepsy
2026-02-01 22:25:32
Check Details
Analysis on how to adjust the medication regimen after complete drug resistance to Mobosetinib (Anvili)
2026-02-01 22:25:32
Check Details
Skin care and side effects prevention methods during Tepotinib (Tuodekang) treatment
2026-02-01 22:25:32
Check Details
How to correct the missed dose of Regorafenib (Belvango) and medication safety reminders
2026-02-01 22:25:32
Check Details
Analysis of contraindications and risk groups for taking Pazopanib (Victor)
2026-02-01 22:25:32
Check Details
Comparison of the efficacy and side effects of Opicapone and entacapone
2026-02-01 22:25:32
Check Details
What kind of drugs does Fenelidone (Keshenda) belong to and its mechanism of action is comprehensively analyzed
2026-02-01 22:25:32
Check Details
Analysis of the advantages of early intervention with rasagiline in the treatment of Parkinson's disease
2026-02-01 22:25:32
Check Details
How long does it take for Platinib (Pujihua) capsules to be absorbed by the body after taking them?
2026-02-01 22:25:32
Check Details
Analysis of how long it will take for the side effects of Capmatinib (Tourad) to gradually disappear after stopping the drug
2026-02-01 22:25:32
Check Details
Possible side effects and harm to health of Leborexan (Daveco)
2026-02-01 22:25:32
Check Details
1
2
...
2023
2024
2025
2026
2027
2028
2029
...
10240
10241
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
2
Selumetinib for NF1-Related Plexiform Neurofibromas: Time to Response and Response Assessment
3
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
4
Ganaxolone Common Side Effects: Somnolence, Sedation and Safety Notes
5
Baxdrostat: Efficacy and Safety of a Novel Aldosterone Synthase Inhibitor
6
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
7
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
8
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks
9
FDA Accelerated Approval of Voceryq: First Plasmid DNA Immunotherapy for Adult Recurrent Respiratory Papillomatosis
10
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
11
Revumenib: Key Considerations Before and During Treatment
12
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control